Breath Test for Early Detection of Lung Cancer
Completed
- Conditions
- Lung Neoplasms
- Registration Number
- NCT00639067
- Lead Sponsor
- Menssana Research, Inc.
- Brief Summary
To demonstrate and validate a breath test for detection of early stage lung cancer that could potentially reduce number of deaths.
- Detailed Description
This is a multicenter study comparing several groups of subjects with and without lung cancer by CT scan, biopsy and the breath test. The breath test will be performed to validate the methodology and the predictive algorithm that were previously developed.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 215
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sensitivity and specificity of the breath test as compared to CT and pathology to support primary lung cancer diagnosis. 30 days after completion.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (4)
Christiana Hospital
🇺🇸Newark, Delaware, United States
MD Anderson Cancer Center
🇺🇸Orlando, Florida, United States
New York University Medical Center
🇺🇸New York, New York, United States
Swedish Cancer Institute
🇺🇸Seattle, Washington, United States
Christiana Hospital🇺🇸Newark, Delaware, United States